Navigation Links
Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology
Date:7/16/2009

INDIANAPOLIS and PERTH, Australia, July 16 /PRNewswire/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and NemGenix, a Perth based biotechnology company, announced today a newly established collaboration agreement to pursue novel technologies to produce nematode-resistant crops.

The collaboration will support a number of full-time researchers at NemGenix's facilities in Perth. Financial terms of the agreement were not disclosed.

"This exciting collaboration capitalizes on the strengths of both Dow AgroSciences and NemGenix to develop next-generation technology to help combat parasitic nematodes, which plague millions of crop acres across the globe," said Daniel R. Kittle, Ph.D., vice president of R&D for Dow AgroSciences. "Dow AgroSciences is continuously exploring and leveraging enabling technologies -- such as those from NemGenix -- to provide new crop protection solutions that benefit growers around the world."

Sean Hird, Ph.D., chief executive officer of NemGenix, said, "This multi-year collaboration is a key milestone in our corporate development and underscores our growing reputation as one of Australia's most exciting new biotechnology companies. Our research team is excited to have the opportunity to build on our expertise in nematode control with the strength and capabilities of a partner such as Dow AgroSciences."

About NemGenix

NemGenix is a privately held agricultural biotechnology company based at the Western Australia State Agricultural Biotechnology Centre in Perth. The company's focus is the research and development of new controls for plant parasitic nematodes. These endemic soil borne pathogens are estimated to cause $15bn of crop damage worldwide with losses of more than 15 percent in some crops, such as sugar cane. The company is currently funded by the Australian Government Department of Education, Science and Training to undertake the development of nematode resistant wheat. See www.nemgenix.com.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.


'/>"/>
SOURCE Dow AgroSciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
2. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
3. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
4. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
5. Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
6. Regado Biosciences Establishes Medical Advisory Board
7. DFG establishes 14 new research training groups
8. Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
9. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
10. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
11. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published ... frozen and fresh in vitro fertilization (IVF) transfer cycles. The multi-center ... success. , After comparing the results from the fresh and frozen transfer cohorts, ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/10/2017)... ... 10, 2017 , ... The Pittcon Program Committee is pleased ... scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each ... leading conference and exposition for laboratory science, which will be held February 26-March ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
Breaking Biology News(10 mins):